Zepp Health [ZEPP] vs Voxx International [VOXX] Detailed Stock Comparison
Zepp Health
NYSE
Loading...
Voxx International
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Zepp Health wins in 8 metrics, Voxx International wins in 10 metrics, with 0 ties. Voxx International appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Zepp Health | Voxx International | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -5.31 | -4.31 | Zepp Health |
| Price-to-Book Ratio | 1.57 | 0.67 | Voxx International |
| Debt-to-Equity Ratio | 47.49 | 12.06 | Voxx International |
| PEG Ratio | -2,239.00 | -9.26 | Zepp Health |
| EV/EBITDA | -105.68 | -5.78 | Zepp Health |
| Profit Margin (TTM) | -38.81% | -18.06% | Voxx International |
| Operating Margin (TTM) | -10.27% | -9.42% | Voxx International |
| Return on Equity | -28.32% | -33.66% | Zepp Health |
| Return on Assets (TTM) | -5.10% | -5.14% | Zepp Health |
| Free Cash Flow (TTM) | $-25.88M | $-23.25M | Voxx International |
| 1-Year Return | 849.22% | -9.53% | Zepp Health |
| Price-to-Sales Ratio (TTM) | 1.61 | 0.43 | Voxx International |
| Enterprise Value | $4.47B | $140.83M | Zepp Health |
| EV/Revenue Ratio | 22.34 | 0.35 | Voxx International |
| Gross Profit Margin (TTM) | 37.27% | 21.25% | Zepp Health |
| Revenue per Share (TTM) | $12 | $17 | Voxx International |
| Earnings per Share (Diluted) | $-4.80 | $-3.09 | Voxx International |
| Beta (Stock Volatility) | 1.12 | 1.07 | Voxx International |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Zepp Health vs Voxx International Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Zepp Health | -4.07% | 80.53% | 598.28% | 860.47% | 740.83% | 746.69% |
| Voxx International | 0.00% | 0.13% | 0.67% | 2.46% | 20.77% | 2.46% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Zepp Health | 849.22% | 197.79% | -58.39% | -46.62% | -46.62% | -46.62% |
| Voxx International | -9.53% | -15.92% | 110.08% | -18.12% | -5.66% | -44.61% |
Performance & Financial Health Analysis: Zepp Health vs Voxx International
| Metric | ZEPP | VOXX |
|---|---|---|
| Market Information | ||
| Market Cap | $321.70M | $168.96M |
| Market Cap Category | Small cap | Micro cap |
| 10 Day Avg. Volume | 333,011 | 130,907 |
| 90 Day Avg. Volume | 1,044,594 | 166,929 |
| Last Close | $24.30 | $7.50 |
| 52 Week Range | $2.08 - $27.86 | $2.27 - $8.40 |
| % from 52W High | -12.78% | -10.71% |
| All-Time High | $81.00 (Feb 15, 2021) | $72.50 (Mar 06, 2000) |
| % from All-Time High | -70.00% | -89.66% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.46% | -0.22% |
| Quarterly Earnings Growth | 5.89% | -0.22% |
| Financial Health | ||
| Profit Margin (TTM) | -0.39% | -0.18% |
| Operating Margin (TTM) | -0.10% | -0.09% |
| Return on Equity (TTM) | -0.28% | -0.34% |
| Debt to Equity (MRQ) | 47.49 | 12.06 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $14.22 | $11.24 |
| Cash per Share (MRQ) | $0.22 | $0.28 |
| Operating Cash Flow (TTM) | $-25,970,000 | $7.34M |
| Levered Free Cash Flow (TTM) | $-134,703,985 | $6.18M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Zepp Health vs Voxx International
| Metric | ZEPP | VOXX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -5.31 | -4.31 |
| Forward P/E | -2,239.00 | -9.26 |
| PEG Ratio | -2,239.00 | -9.26 |
| Price to Sales (TTM) | 1.61 | 0.43 |
| Price to Book (MRQ) | 1.57 | 0.67 |
| Market Capitalization | ||
| Market Capitalization | $321.70M | $168.96M |
| Enterprise Value | $4.47B | $140.83M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 22.34 | 0.35 |
| Enterprise to EBITDA | -105.68 | -5.78 |
| Risk & Other Metrics | ||
| Beta | 1.12 | 1.07 |
| Book Value per Share (MRQ) | $14.22 | $11.24 |
Financial Statements Comparison: Zepp Health vs Voxx International
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ZEPP | VOXX |
|---|---|---|
| Revenue/Sales | $38.54M | $105.18M |
| Cost of Goods Sold | $24.18M | $82.83M |
| Gross Profit | $14.36M | $22.35M |
| Research & Development | $12.38M | $8.32M |
| Operating Income (EBIT) | $-18.38M | $-9.90M |
| EBITDA | $-17.79M | $-6.48M |
| Pre-Tax Income | $-19.27M | $-49.97M |
| Income Tax | $110,000 | $-513,000 |
| Net Income (Profit) | $-19.74M | $-49.46M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ZEPP | VOXX |
|---|---|---|
| Cash & Equivalents | $76.43M | $6.35M |
| Total Current Assets | $242.46M | $202.15M |
| Total Current Liabilities | $212.34M | $109.24M |
| Long-Term Debt | $71.16M | $18.61M |
| Total Shareholders Equity | $232.04M | $200.34M |
| Retained Earnings | $8.88M | $7.45M |
| Property, Plant & Equipment | $9.56M | $38.00M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ZEPP | VOXX |
|---|---|---|
| Operating Cash Flow | $-14.63M | $-45.54M |
| Capital Expenditures | $-2.92M | $-4.80M |
| Free Cash Flow | $-16.89M | $17.79M |
| Debt Repayment | N/A | $-76.82M |
| Common Stock Repurchase | N/A | $0 |
Short Interest & Institutional Ownership Analysis
| Metric | ZEPP | VOXX |
|---|---|---|
| Shares Short | 308,546 | N/A |
| Short Ratio | 0.25 | N/A |
| Short % of Float | 0.05% | N/A |
| Average Daily Volume (10 Day) | 333,011 | 130,907 |
| Average Daily Volume (90 Day) | 1,044,594 | 166,929 |
| Shares Outstanding | 231.98M | 21.96M |
| Float Shares | 108.71M | 11.07M |
| % Held by Insiders | 0.06% | 0.66% |
| % Held by Institutions | 0.26% | 0.68% |
Dividend Analysis & Yield Comparison: Zepp Health vs Voxx International
| Metric | ZEPP | VOXX |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | $0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |